Integrated in silico and in vivo approaches reveal naltrexone as a synergistic modulator of TLR4 and μ-opioid receptors restoring redox homeostasis via Nrf2/Keap-1/HO-1 and HIF-1α/VEGF pathways in COPD
Aug 2026 · Molecular and Cellular Biochemistry · Vol 481, pp. 4963 - 4985 · 0 citations
· 61 references
Medicine